Liraglutide, a once-daily human GLP-1 analog, reverses indices of prediabetes in obese subjects: A randomized placebo-controlled 20-week trial

Research output: Contribution to journalConference abstract in journalResearch

  • Nick Finer
  • Mazin Al Hakim
  • Astrup, Arne
  • Angela Harper
  • Mike Lean
  • Mads F. Rasmussen
  • Alla Rissanen
  • Stephan Rössner
  • Luc van Gaal
Original languageEnglish
JournalDiabetes
Volume58
Issue numbersuppl. 1
Pages (from-to)A443-A444
Number of pages2
ISSN0012-1797
Publication statusPublished - 2009
EventScientific Sessions of the American Diabetes Association - New Orleans, United States
Duration: 5 Jun 20099 Jun 2009
Conference number: 69

Conference

ConferenceScientific Sessions of the American Diabetes Association
Number69
CountryUnited States
CityNew Orleans
Period05/06/200909/06/2009

ID: 12623351